This is a match-making section for OHAMR Call for proposals 2026.
H - Human Health
Clinical and Molecular Microbiology; Genomics; Bioinformatics; Drug Resistance
Professor at the Faculty of Pharmacy, University of Lisbon, and Principal Investigator at the Research Institute for Medicines (iMed). My research focuses on the molecular epidemiology and evolution of multidrug-resistant bacterial pathogens. I apply integrative approaches combining phenotypic assays, high-throughput sequencing (Illumina, PacBio, Nanopore), and bioinformatic analyses to study antimicrobial resistance, bacterial adaptation, and transmission dynamics. Ongoing Projects / Highlights: • Genomic epidemiology and comparative genomics of M. tuberculosis and Gram-negative bacteria (e.g., Klebsiella pneumoniae). • Development of the CPLP-TB platform for tracking tuberculosis strains across Lusophone countries. • Studies on persistence and drug tolerance mechanisms using transcriptomic profiling and computational biology approaches. My expertise lies in phenotypic testing, next generation sequencing (NGS), bioinformatic analysis, and resistome profiling, which can be applied to study microbial communities, track the dissemination of resistance genes, and assess public health risks associated with waterborne bacteria.
I am particularly keen to collaborate on initiatives involving environmental surveillance of antimicrobial resistance, microbial source tracking, and the integration of genomic data to public health and drug development.
Submitted on 2026-01-22 07:17:06
« Return to the partner search tool